Format

Send to

Choose Destination
PLoS One. 2014 Apr 8;9(4):e94063. doi: 10.1371/journal.pone.0094063. eCollection 2014.

Breast cancer "tailored follow-up" in Italian oncology units: a web-based survey.

Author information

1
Department of Experimental and Clinical Sciences, University "G. d'Annunzio", Chieti, Italy.
2
Unit of Biostatistics, Regina Elena National Cancer Institute, Rome, Italy.
3
Oncology Department, "Floraspe Renzetti" Hospital, Lanciano, Italy.
4
Clinical Governance Unit, "SS. Annunziata" Hospital, Chieti, Italy.
5
Department of Oncology, "S.S. Trinita'" Hospital, Sora, Italy.
6
Division of Medical Oncology B, Regina Elena National Cancer Institute, Rome, Italy.

Abstract

PURPOSE:

Breast cancer follow-up procedures after primary treatment are still a controversial issue. Aim of this study was to investigate, through a web-based survey, surveillance methodologies selected by Italian oncologists in everyday clinical practice.

METHODS:

Referents of Italian medical oncology units were invited to participate to the study via e-mail through the SurveyMonkey website. Participants were asked how, in their institution, exams of disease staging and follow-up are planned in asymptomatic women and if surveillance continues beyond the 5th year.

RESULTS:

Between February and May 2013, 125 out of 233 (53.6%) invited referents of Italian medical oncology units agreed to participate in the survey. Ninety-seven (77.6%) referents state that modalities of breast cancer follow-up are planned according to the risk of disease progression at diagnosis and only 12 (9.6%) oncology units apply the minimal follow-up procedures according to international guidelines. Minimal follow-up is never applied in high risk asymptomatic women. Ninety-eight (78.4%) oncology units continue follow-up in all patients beyond 5 years.

CONCLUSIONS:

Our survey shows that 90.4% of participating Italian oncology units declare they do not apply the minimal breast cancer follow-up procedures after primary treatment in asymptomatic women, as suggested by national and international guidelines. Interestingly, about 80.0% of interviewed referents performs the so called "tailored follow-up", high intensity for high risk, low intensity for low risk patients. There is an urgent need of randomized clinical trials able to determine the effectiveness of risk-based follow-up modalities, their ideal frequency and persistence in time.

PMID:
24714591
PMCID:
PMC3979748
DOI:
10.1371/journal.pone.0094063
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center